These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34689252)

  • 1. Steady-state ferumoxytol-enhanced MRI: early observations in benign abdominal organ masses and clinical implications.
    Shahrouki P; Felker ER; Raman SS; Jeong WK; Lu DS; Finn JP
    Abdom Radiol (NY); 2022 Jan; 47(1):460-470. PubMed ID: 34689252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ferumoxytol-enhanced MR imaging for differentiating intrapancreatic splenules from other tumors.
    Muehler MR; Rendell VR; Bergmann LL; Winslow ER; Reeder SB
    Abdom Radiol (NY); 2021 May; 46(5):2003-2013. PubMed ID: 33377995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of ferumoxytol and gadoteridol enhancement using T1- and T2-weighted MRI in neuroimaging.
    Hamilton BE; Nesbit GM; Dosa E; Gahramanov S; Rooney B; Nesbit EG; Raines J; Neuwelt EA
    AJR Am J Roentgenol; 2011 Oct; 197(4):981-8. PubMed ID: 21940589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Imaging behavior of the normal adrenal on ferumoxytol-enhanced MRI: preliminary findings.
    Gunn AJ; Seethamraju RT; Hedgire S; Elmi A; Daniels GH; Harisinghani MG
    AJR Am J Roentgenol; 2013 Jul; 201(1):117-21. PubMed ID: 23789664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ferumoxytol Does Not Impact Standardized Uptake Values on PET/MR Scans.
    Muehe AM; Yerneni K; Theruvath AJ; Thakor AS; Pribnow A; Avedian R; Steffner R; Rosenberg J; Hawk KE; Daldrup-Link HE
    Mol Imaging Biol; 2020 Jun; 22(3):722-729. PubMed ID: 31325083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of ferumoxytol for high-resolution vascular imaging and troubleshooting for abdominal allografts.
    Shah A; Neitzel E; Panda A; Fananapazir G
    Abdom Radiol (NY); 2024 Aug; 49(8):2858-2872. PubMed ID: 38561553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential for differentiation of pseudoprogression from true tumor progression with dynamic susceptibility-weighted contrast-enhanced magnetic resonance imaging using ferumoxytol vs. gadoteridol: a pilot study.
    Gahramanov S; Raslan AM; Muldoon LL; Hamilton BE; Rooney WD; Varallyay CG; Njus JM; Haluska M; Neuwelt EA
    Int J Radiat Oncol Biol Phys; 2011 Feb; 79(2):514-23. PubMed ID: 20395065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of ferumoxytol with gadolinium as contrast agents for the diagnostic magnetic resonance imaging of osteomyelitis.
    Langsjoen J; Neuwelt A; Eberhardt S; Mlady G; Shukla U; Murali S; Pizanis C; Sillerud LO
    Magn Reson Imaging; 2020 Sep; 71():45-54. PubMed ID: 32439428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation of benign and malignant lymph nodes in pediatric patients on ferumoxytol-enhanced PET/MRI.
    Muehe AM; Siedek F; Theruvath AJ; Seekins J; Spunt SL; Pribnow A; Hazard FK; Liang T; Daldrup-Link H
    Theranostics; 2020; 10(8):3612-3621. PubMed ID: 32206111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging Tumor Necrosis with Ferumoxytol.
    Aghighi M; Golovko D; Ansari C; Marina NM; Pisani L; Kurlander L; Klenk C; Bhaumik S; Wendland M; Daldrup-Link HE
    PLoS One; 2015; 10(11):e0142665. PubMed ID: 26569397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferumoxytol-Enhanced MRI Is Not Inferior to Gadolinium-Enhanced MRI in Detecting Intracranial Metastatic Disease and Metastasis Size.
    Hamilton BE; Barajas R; Nesbit GM; Fu R; Ambady P; Taylor M; Neuwelt EA
    AJR Am J Roentgenol; 2020 Dec; 215(6):1436-1442. PubMed ID: 33052739
    [No Abstract]   [Full Text] [Related]  

  • 12. Ferumoxytol-Enhanced Magnetic Resonance Imaging in Late-Stage CKD.
    Mukundan S; Steigner ML; Hsiao LL; Malek SK; Tullius SG; Chin MS; Siedlecki AM
    Am J Kidney Dis; 2016 Jun; 67(6):984-8. PubMed ID: 26786296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Incidental ferumoxytol artifacts in clinical brain MR imaging.
    Bowser BA; Campeau NG; Carr CM; Diehn FE; McDonald JS; Miller GM; Kaufmann TJ
    Neuroradiology; 2016 Nov; 58(11):1087-1091. PubMed ID: 27704163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging applications for ferumoxytol as a contrast agent in MRI.
    Bashir MR; Bhatti L; Marin D; Nelson RC
    J Magn Reson Imaging; 2015 Apr; 41(4):884-98. PubMed ID: 24974785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. How to stop using gadolinium chelates for magnetic resonance imaging: clinical-translational experiences with ferumoxytol.
    Daldrup-Link HE; Theruvath AJ; Rashidi A; Iv M; Majzner RG; Spunt SL; Goodman S; Moseley M
    Pediatr Radiol; 2022 Feb; 52(2):354-366. PubMed ID: 34046709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ferumoxytol-enhanced magnetic resonance angiography provides comparable vascular conspicuity to CT angiography in dogs with intrahepatic portosystemic shunts.
    Wilson S; Culp WTN; Wisner ER; Cissell DD; Finn JP; Zwingenberger AL
    Vet Radiol Ultrasound; 2021 Jul; 62(4):463-470. PubMed ID: 33634935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide resovist versus gadolinium-DTPA in the same patient.
    Vogl TJ; Hammerstingl R; Schwarz W; Kümmel S; Müller PK; Balzer T; Lauten MJ; Balzer JO; Mack MG; Schimpfky C; Schrem H; Bechstein WO; Neuhaus P; Felix R
    Invest Radiol; 1996 Nov; 31(11):696-708. PubMed ID: 8915751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol.
    Luhar A; Khan S; Finn JP; Ghahremani S; Griggs R; Zaritsky J; Salusky I; Hall TR
    Pediatr Radiol; 2016 Aug; 46(9):1332-40. PubMed ID: 27059620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular applications of ferumoxytol-enhanced magnetic resonance imaging of the abdomen and pelvis.
    Bowman AW; Gooch CR; Alexander LF; Desai MA; Bolan CW
    Abdom Radiol (NY); 2021 May; 46(5):2203-2218. PubMed ID: 33090256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved Detection of Bone Metastases in Children and Young Adults with Ferumoxytol-enhanced MRI.
    Rashidi A; Baratto L; Theruvath AJ; Greene EB; Jayapal P; Hawk KE; Lu R; Seekins J; Spunt SL; Pribnow A; Daldrup-Link HE
    Radiol Imaging Cancer; 2023 Mar; 5(2):e220080. PubMed ID: 36999999
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.